WHO BTIF [Regulatives / Guidelines]

posted by Ohlbe – France, 2012-01-13 19:41 (5279 d 02:39 ago) – Posting: # 7938
Views: 6,606

Dear Helmut and Karthik,

❝ ❝ its possible to compare our study report with reference literature?


❝ Sure, but of limited value.


On a PK and BE point of view, I would say the global CV has no value at all.

But I've heard some regulators say that they have seen studies with a global CV which was surprisingly low (10 %, for AUC and Cmax). When inspected, the studies turned out to be totally invented, falsified... So on a regulatory point of view, the global CV and its comparison with other trials (including literature data) may provide some other level of information...

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
325 visitors (0 registered, 325 guests [including 23 identified bots]).
Forum time: 23:21 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5